Service delivery area
Civil society groups across Eastern Europe and Central Asia are consolidating resources and presenting a unified front to national governments to call for a greater domestic investment in harm reduction as part of the HIV response.
The concept note delivered on 8 September for Russia's last HIV grant from the Global Fund was a perfect illustration of the conundrum facing a growing number of Eastern European/Central Asian countries: how to do more with less to fight a widening HIV epidemic.
Ukraine's HIV community including principal recipients of Global Fund grants have formally requested that grant signing for Phase 2 of a Round 10 HIV grant be expedited to mitigate the potential impact of the current political turmoil roiling the country.
Russia has announced its pledge to commit $60 million to the Global Fund’s fourth replenishment cycle ahead of the anticipated end in 2014 of all Global Fund grants to the country.
The Global Fund is participating in an initiative to leverage private sector funding to speed up delivery of, and expand access to, health products such as contraceptives, bed nets and medicines. The initiative is called the “Pledge Guarantee for Health.”
In an email sent to Board members on 7 March, Global Fund Executive Director Mark Dybul explained how indicative allocations for early and interim applicants could be adjusted to account for qualitative factors and other variables.
In conjunction with the introduction of the new funding model (NFM), the Global Fund is introducing a new, modular approach for describing the programmes for which applicants are requesting funding.
What the Global Fund calls the “taxonomy” of the modular approach is explained in the following diagram taken from a near-final draft of the Concept Note Instructions for Early Applicants.
The Coca-Cola Company and the Global Fund are expanding a project which uses Coca-Cola’s distribution systems and business expertise to help government and non-governmental organisations deliver critical medicines to remote parts of Africa, according to a news
The Global Fund is continuing to experience solid growth in terms of services provided and the numbers of people reached through programmes supported by the Fund, even as reduced estimates of available resources are forcing the Fund to tighten its belt.
According to data compiled by the Global Fund, since the introduction of the Affordable Medicines Facility-malaria (AMFm) programme, the average cost of a course of artemisinin combination therapy (ACT) in private pharmacies has dropped by about 90% in parts of Kenya and by about 40% to 90% in Ghana, the first two countries to participate in the programme.